Search results for: Consulting Reports
Filter search results
Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK
31 March 2015
A new OHE Consulting Report considers the data capabilities in the UK for monitoring medicine use according to indication using real world data. In the UK and across the world,…
Public Health and Economic Implications of the United Kingdom Exiting the EU and the Single Market
12 December 2017
…OHE Consulting report explores the consequences of the exit of the United Kingdom (UK) from the European Union (EU), ‘Brexit’, on public health in the UK and in the EU….
OHE’s In-house Publications Are Now Indexed by RePEc
8 May 2018
…our website. We publish Research Papers, Consulting Reports, and several other series. Now, in addition to being able to access OHE’s in-house publications via our website, you can access them…
International Comparisons of Medicines Prices: 2011 Indices
1 October 2012
…Consulting uses the same methodology in this report to update comparisons through 2011. Since 1996, in its yearly PPRS Report to Parliament, the Department of Health in England has published…
Just Released: Health and the Use of Medicines in Wales
3 November 2011
In this report commissioned by the ABPI in Wales, OHE Consulting examines the use of medicines in primary care in Wales since 2000 compared to the other countries of the…
Do Respondents Completing Abstract, Hypothetical Priority-Setting Exercises Agree with the Policy Implications of Their Choices?
3 March 2015
A new OHE Consulting Report examines whether respondents completing abstract, hypothetical priority-setting exercises in stated preference studies agree with the policy implications of their choices. Stated preference studies are increasingly…
Minimal Access Surgery – Why Don’t We Do More?
20 March 2018
OHE Consulting publishes a report on the barriers to the uptake of minimal access surgery in the NHS and private sector. Surgical practice has come a long way, barely recognisable…
Appraising Ultra-Orphan Drugs: Is Cost-per-QALY Appropriate?
22 March 2018
A new OHE report discusses NICE’s introduction of a cost-effectiveness threshold to appraise ultra-orphan drugs. A new OHE Consulting Report has been published that discusses the use of a cost-per-QALY…
A Critique of Hill et al. (2018) on Estimated Costs of Production for the WHO Essential Medicines List
19 May 2018
OHE Consulting produces a report critiquing a paper by Hill et al. (2018) on estimated costs of production for the WHO Essential Medicines List. This OHE Consulting Report, published today,…